Full Access
REDUCING THE RISK OF VIRUS TRANSMISSION BY BLOOD PRODUCTS
Duncan P. Thomas,
Corresponding Author
Duncan P. Thomas
National Institute for Biological Standards and Control, Potters Bar, Herts.
Dr Duncan P. Thomas, National Institute for Biological Standards and Control, Potters Bar, Herts. EN6 3QG.Search for more papers by this authorDuncan P. Thomas,
Corresponding Author
Duncan P. Thomas
National Institute for Biological Standards and Control, Potters Bar, Herts.
Dr Duncan P. Thomas, National Institute for Biological Standards and Control, Potters Bar, Herts. EN6 3QG.Search for more papers by this author
References
- Acquired immunodeficiency syndrome (AIDS) (1986) WHO Weekly Epidemiological Record, No. 18, p. 40.
- Bove, J. (1987) Transfusion-associated hepatitis and AIDS. What is the risk New England Journal of Medicine, 317, 242 – 245.
- Bove, J.R. & Sandler, S.G. (1988) HTLV-1 and blood transfusion. Transfusion, 28, 93 – 94.
- Centers for Disease Control, Atlanta (1986) Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotrophic virus type III lymphadenopathy-associated virus infection. Morbidity and Mortality Weekly Report, 35, 231 – 233.
- Centers for Disease Control, Atlanta (1988) Safety of therapeutic products used for hemophilia patients. Morbidity and Mortality Weekly Report, 37, 441 – 444.
- Cuthbertson, B., Perry, R.J., Foster, P.R., Reid, K.G., Crawford, R.J. & Yap, P.L. (1987) Factors influencing the viral safety of intravenous immunoglobulin. Journal of Infection, 15, 125 – 133.
- Editorial, HIV-2 in Perspective (1988) Lancet, i, 1027 – 1028.
- Eibl, J., Kaeser, A., Heimburger, N., et al (1988) Ways to reduce the risk of transmission of viral infections by plasma and plasma products. A comparison of methods, their advantages and disadvantages. Vox Sanguinis, 54, 228 – 245.
- Furesz, J. (1987) Bureau of Biologics, Ottawa , Canada . Personal communication.
- Gillon, J., Hussey, A.J., Howe, S.P., Beckett, G.J. & Prescott, R.J. (1988) Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors. Vox Sanguinis, 54, 148 – 153.
- Gunson, H.H. & Rawlinson, V.I. (1988) HIV antibody screening of blood donations in the United Kingdom. Vox Sanguinis, 54, 34 – 38.
- Lancet Notes and News (1988) Lancet, ii, 233.
-
Horowitz, M.S.,
Rooks, C.,
Horowitz, B. &
Hilgartner M.W. (1988) Virus safety of solvent/detergent-treated antihaemophilic factor concentrate.
Lancet, ii, 186
–
189.
10.1016/S0140-6736(88)92288-X Google Scholar
- Lever, M.L., Webster, A.D.B., Brown, D. & Thomas H.C. (1984) Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet, ii, 1062 – 1064.
- Loche, M. & Mach, B. (1988) Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridization of amplified DNA. Lancet, ii, 418 – 421.
- R. Madhook, C.D. Forbes & B.L. Evatt (1987) Blood, Blood Products and AIDS. Chapman & Hall, London .
- Mannucci, P.M. (1987) Evaluation of safety of heated antihemophilic concentrate. Hemophilia World, 4, 4 – 6.
- McDougal, J.S., Martin, L.S., Cort, S.P., Mozen, M., Hellebrant, C.M. & Evatt, B.L. (1985) Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotrophic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. Journal of Clinical Investigation, 76, 875 – 877.
- Nature News (1988) Candidate cause identified of non-A, non-B hepatitis. Nature, 333, 195.
-
Ochs, H.D.,
Fischer, S.H.,
Virant, F.S.,
Lee, M.L.,
Kingdon, H.S. &
Wedgwood, R.J. (1985) Non-A, non-B hepatitis and intravenous immunoglobulin.
Lancet, i, 404
–
405.
10.1016/S0140-6736(85)91430-8 Google Scholar
- I.D. Petricciani, P. Gust, A. Hoppe & H.W. Krijnen (1987) AIDS: The Safety of Blood and Blood Products. John Wiley, Chichester .
-
Petricciani, J.C.,
McDougal, J.S. &
Evatt, B.L. (1985) Case for concluding that heat-treated licensed anti-haemophilic factor is free from HTLV-III.
Lancet, ii, 890
–
891.
10.1016/S0140-6736(85)90155-2 Google Scholar
- Piszkiewicz, D., Bourrett, L., Liew, M., et al (1987) Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates. Thrombosis Research, 47, 235 – 241.
- Prince, A.M., Horowitz, B. & Brotman, B. (1986) Sterilization of hepatitis and HTLV-III virus by exposure to tri (n-butyl) phosphate and sodium cholate. Lancet, i, 706 – 710.
- Saiki, R.K., Scharf, S., Faloona, F., et al (1985) Enzymatic amplification of alpha-globulin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350 – 1354.
- Schimpf, K., Mannucci, P.M., Kreutz, W., et al (1987) Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. New England Journal of Medicine, 316, 918 – 922.
- Study Group of the U.K. Haemophilia Centre Directors (1988) Effect of dry-heating of coagulation factor concentrates at 80°C for 72 hours on transmission of non-A, non-B hepatitis. Lancet, ii, 814 – 816.
- Survey of non-US hemophilia centers for HIV seroconversion following therapy with heat-treated factor concentrates (1987) Morbidity and Mortality Weekly Report, 36, 121.
-
van Den Berg, W.,
Ten Cate, J.W.,
Breederveld, C. &
Goudsmit, J. (1986) Seroconversion to HTLV-III in haemophiliac given heat-treated factor VIII concentrate.
Lancet, i, 803
–
804.
10.1016/S0140-6736(86)91814-3 Google Scholar
- Wagstaff, W. (1987) Quality assurance of transfusion centre derived blood products. Progress in Transfusion Medicine ( J. D. Cash). Vol. 2, pp. 1 – 20. Churchill Livingstone, Edinburgh .
- Weiland, O., Mattson, L. & Glaumann, H. (1986) Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet, i, 976 – 977.
- Wells, M., Witteck, A., Epstein, J., et al (1986) Inactivation and partition of human T-cell lymphotropic virus, type III, during ethanol fractionation of plasma Transfusion, 26, 210 – 213.
- White, G.C., Matthews, T.J., Weinhold, K.J., Haynes, B.F., Cromartie, H.L., McMillan, C.W. & Bolognesi, D.P. (1987) HTLV-III seroconversion associated with heat-treated factor VIII concentrate. Lancet, i, 611 – 612.
- WHO (1986) Acquired Immunodeficiency Syndrome (AIDS). WHO meeting and consultation on the safety of blood and blood products (1986). WHO Weekly Epidemiological Record, No. 18, pp. 138 – 140.
Citing Literature
